South African billionaire Stephen Saad’s Aspen Pharmacare wins approval for generic semaglutide in Brazil and South Africa
Billionaires Africa | 11.11.2026 20:16
Stephen Saad's Aspen Pharmacare has won regulatory approval in Brazil and South Africa for its generic injectable semaglutide, paving the way for launches in two key emerging markets.
